Pharmagen(OTC) PHRX

Pharmagen, Inc. is a pharmaceutical company based in Silver Spring, Maryland, specializing in the distribution of specialty drugs within the U.S. healthcare market. The company provides a diverse range of medical products, including plasma derivatives, vaccines, and health supplements, catering to various healthcare practitioners nationwide.

Products and Services

• Distribution of specialty pharmaceuticals and blood plasma derivatives
• Production and sale of health supplements, including Clotamin
• Supply of traditional pharmaceuticals, such as antibiotics and vaccines

Growth Outlook

• Focus on expanding plasma derivative offerings for critical health conditions
• Increasing demand for specialty drugs in hospitals and surgical facilities
• Strategic partnerships to enhance product distribution capabilities

Financial Highlights

• Recent quarterly revenue of 1,319.464, showing growth from previous quarters
• Gross profit margin of 55.8% indicates strong product demand
• Current ratio of 0.11 suggests potential liquidity challenges

Pharmagen, Inc. operates in a vital sector of the healthcare industry, providing essential medications and health products. The company's focus on specialty pharmaceuticals, particularly plasma derivatives, positions it well to meet the growing needs of healthcare providers. Recent financial data indicates a positive trend in revenue, reflecting the increasing demand for its products. However, the current ratio suggests that liquidity may be a concern, warranting attention as the company continues to navigate its growth trajectory. Overall, Pharmagen presents an intriguing opportunity within the pharmaceutical distribution landscape.